Cohen Klingenstein LLC held its position in Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 34,600 shares of the company’s stock at the end of the second quarter. Cohen Klingenstein LLC’s holdings in Colgate-Palmolive were worth $2,565,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. Palo Capital Inc. boosted its position in shares of Colgate-Palmolive by 1.6% in the second quarter. Palo Capital Inc. now owns 20,513 shares of the company’s stock valued at $1,521,000 after buying an additional 320 shares during the last quarter. Winslow Evans & Crocker Inc. boosted its position in shares of Colgate-Palmolive by 3.3% in the second quarter. Winslow Evans & Crocker Inc. now owns 32,645 shares of the company’s stock valued at $2,419,000 after buying an additional 1,037 shares during the last quarter. OLD National Bancorp IN boosted its position in shares of Colgate-Palmolive by 8.3% in the second quarter. OLD National Bancorp IN now owns 10,280 shares of the company’s stock valued at $762,000 after buying an additional 791 shares during the last quarter. Mn Services Vermogensbeheer B.V. boosted its position in shares of Colgate-Palmolive by 505.1% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 136,621 shares of the company’s stock valued at $10,128,000 after buying an additional 114,044 shares during the last quarter. Finally, Woodstock Corp boosted its position in shares of Colgate-Palmolive by 8.8% in the second quarter. Woodstock Corp now owns 39,966 shares of the company’s stock valued at $2,963,000 after buying an additional 3,238 shares during the last quarter. 73.74% of the stock is owned by institutional investors.
Shares of Colgate-Palmolive Company (NYSE:CL) opened at 71.48 on Friday. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The firm has a market capitalization of $62.96 billion, a P/E ratio of 26.56 and a beta of 0.80. The company’s 50 day moving average price is $73.87 and its 200 day moving average price is $72.62.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.72. The firm had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business’s quarterly revenue was down .5% compared to the same quarter last year. During the same period last year, the company earned $0.70 EPS. On average, analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, July 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.24%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.
WARNING: “Cohen Klingenstein LLC Continues to Hold Stake in Colgate-Palmolive Company (NYSE:CL)” was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://stocknewstimes.com/2017/08/06/cohen-klingenstein-llc-has-2565000-stake-in-colgate-palmolive-company-nysecl-updated-updated.html.
A number of research firms have commented on CL. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Thursday, May 25th. UBS AG reiterated a “neutral” rating and set a $78.00 price target (down from $79.00) on shares of Colgate-Palmolive in a research note on Tuesday, May 2nd. BidaskClub lowered shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 12th. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $79.00 price target (up from $77.00) on shares of Colgate-Palmolive in a research note on Monday, July 24th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company’s stock. Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $75.82.
In other Colgate-Palmolive news, SVP John J. Huston sold 14,000 shares of Colgate-Palmolive stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $71.53, for a total transaction of $1,001,420.00. Following the transaction, the senior vice president now directly owns 102,838 shares in the company, valued at $7,356,002.14. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Ellen M. Hancock sold 5,057 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $71.91, for a total value of $363,648.87. Following the completion of the sale, the director now directly owns 199,777 shares in the company, valued at approximately $14,365,964.07. The disclosure for this sale can be found here. Insiders sold a total of 117,097 shares of company stock worth $8,480,638 over the last 90 days. 1.02% of the stock is owned by corporate insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.
